Cell and Gene Therapy Market Set to Reach US$ 25.78 Billion by 2031 at 25.5% CAGR

The global Cell and Gene Therapy Market is expanding as pharmaceutical and biotechnology companies increase their focus on advanced treatments for chronic diseases, genetic disorders, oncology, rare diseases, and personalized medicine. Increasing research activity, biotechnology investments, regulatory support, and technological innovation are contributing to the development and adoption of cell and gene therapies across global healthcare markets. The growing use of innovative therapeutic approaches is also supporting broader clinical development and commercialization activities.

According to The Insight Partners, the Cell and Gene Therapy Market size is projected to reach US$ 25.78 billion by 2031 from US$ 5.30 billion in 2024. The market is expected to register a CAGR of 25.5% during 2025–2031. The substantial expansion in market size reflects increasing demand for advanced therapeutic solutions, growing clinical programs, rising investments, and continued innovation in cell processing, gene editing, manufacturing, and related technologies.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00020854

Cell and Gene Therapy Market Size and Share:

The Cell and Gene Therapy Market size is projected to increase from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031. North America held 40.7% of the global market share in 2024, while Asia Pacific is projected to record a CAGR of 29.1% during the forecast period. The United States market is expected to register a CAGR of 24.5%. By type, cell therapy accounted for the largest market share at 65.7% in 2024.

Cell and Gene Therapy Market Growth Drivers:

Several factors are supporting Cell and Gene Therapy Market growth. The increasing prevalence of chronic and genetic diseases is creating demand for targeted and potentially curative treatment approaches. Rising incidences of cancer, autoimmune conditions, and inherited genetic disorders are encouraging the development of advanced therapies.

Another important driver is the growing use of specialized manufacturing services. The complexity of cell and gene therapy production has increased demand for outsourcing to contract development and manufacturing organizations. This approach can support scalability, cost efficiency, regulatory compliance, and clinical and commercial timelines.

Regulatory developments are also contributing to market expansion. Accelerated regulatory pathways, orphan drug designations, and supportive approval frameworks can facilitate the commercialization of cell and gene therapies, supporting investment and access to innovative treatments.

Cell and Gene Therapy Market Segmentation:

The Cell and Gene Therapy Market is segmented by type, service, scale, service providers, transfection reagents, end user, and geography.

By type, the market includes cell therapy and gene therapy. Cell therapy is supported by increasing adoption in oncology and regenerative medicine, stem cell research, and advances in cell processing and manufacturing. Gene therapy is supported by progress in gene editing technologies, approvals for rare disease treatments, clinical pipelines, and demand for long-term therapeutic solutions.

By service, the market is categorized into process development, cGMP manufacturing, regulatory services, and bioassay services. Process development is anticipated to witness the fastest growth, registering a CAGR of 26.2% during the forecast period.

By scale, the market includes pre-commercial or research and development manufacturing and commercial scale manufacturing. Pre-commercial or research and development manufacturing accounted for the largest share at 66.5% in 2024.

By service providers, the market includes CDMOs and CMOs. The CDMOs segment is anticipated to witness the fastest growth, with a CAGR of 26.1%.

By transfection reagents, the market covers polymer-based transfection reagents, lipid-based transfection reagents, viral transduction enhancers, and others. Lipid-based transfection reagents accounted for the largest share at 47.4% in 2024.

By end user, the market includes contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. Contract research organizations are anticipated to witness the fastest growth, registering a CAGR of 25.9%.

Buy Premium Report:
https://www.theinsightpartners.com/buy/TIPRE00020854

Top Key Players:

The Cell and Gene Therapy Market includes several established companies and specialized industry participants. Key players profiled in the report include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Cell and Gene Therapy Catapult, Lonza Group AG, WuXi AppTec Co Ltd, Takara Bio Inc., FUJIFILM Holdings Corp, F. Hoffmann-La Roche Ltd, and Catalent Inc.

Cell and Gene Therapy Market Growth and Opportunities:

The market presents opportunities through strategic partnerships, acquisitions, technology collaborations, manufacturing expansion, and increased research and development investment. Pharmaceutical and biotechnology companies are using collaborations to strengthen pipelines, enhance manufacturing capabilities, and accelerate commercialization.

Government initiatives also provide opportunities through funding programs, supportive policies, tax incentives, and expedited regulatory pathways. Increasing public and private investment in research and clinical trials is further supporting the exploration and development of new cell and gene therapies.

Future Outlook:

The Cell and Gene Therapy Market future outlook is closely associated with continued technological development, expanding clinical activity, manufacturing innovation, and increasing adoption of advanced therapeutic approaches. Gene editing technologies such as CRISPR and innovations in CAR-T, scalable manufacturing, and automated production systems are supporting the evolution of the industry.

Geographically, Asia Pacific is projected to experience the fastest growth, supported by increasing healthcare spending, government initiatives, and clinical activity in countries including China, Japan, and India. North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa remain important regions covered by the market.

Trending Reports:

· Botulinum Toxin Market Key Players and Opportunities by 2031

· Brachytherapy Devices Market Share, Size & Demand by 2034

· Brain Implants Market Dynamics and Developments by 2030

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.